Stichting Sanquin Bloedvoorziening

Stichting Sanquin Bloedvoorziening is a research organisation in Amsterdam, Netherlands that has taken part in 30 EU-funded projects since 2015, receiving €20.4M in EU funding and leading 6 as coordinator.

EU funding received€20.4M
EU projects30
As coordinator6
Running now14
First EU project2015
Latest project2026
CountryNetherlands
EU registration (PIC)998508010
On this page · 5 sections→

Where the EU money came from

Funding by EU programme. Amounts are Stichting Sanquin Bloedvoorziening's own share of each project, not the project's full budget.

  • Horizon Europe€12.2M · 16 projects
  • Horizon 2020€7.9M · 12 projects
  • EU4Health Programme (EU4H)€208k · 1 project
  • 3rd Health Programme€147k · 1 project

Projects

30 EU-funded projects, newest first. Stichting Sanquin Bloedvoorziening led 6 of them as coordinator. Each links to the official record.

  • X-CITECoordinator

    Uncovering the Role of X Chromsome Inactivation Escapees in T Cell Function

    Horizon Europe · 2026–2028 · Project on CORDIS ↗

    €233ktheir share
  • DONOR-PROTECTCoordinator

    Redefining Standards for Sustainable Blood and Plasma Collections through Personalized Donor Health Protection Strategies

    Horizon Europe · 2026–2031 · Project on CORDIS ↗

    €3.0Mtheir share
  • CoRDSAssociated partner

    Confident data-driven Decision Support

    Horizon Europe · 2026–2029 · Project on CORDIS ↗

  • MakingBloodPartner

    Engineering an integrated platform for generation of human blood stem cells from pluripotent sources

    Horizon Europe · 2025–2031 · Project on CORDIS ↗

    €4.9Mtheir share
  • D-MAPPartner

    Dissecting the Functional Role of Mucosal IgA Clonal and Glycoprofiles for Effective Humoral Mucosal Protection

    Horizon Europe · 2025–2029 · Project on CORDIS ↗

    €113ktheir share
  • Project-COMFORTPartner

    Patient-Centric blOod saMpling FOr impRoved healThcare (Project-COMFORT)

    Horizon Europe · 2024–2028 · Project on CORDIS ↗

    €65ktheir share
  • HIT-GLIOPartner

    Targeting tumour-host interactions in paediatric malignant gliomas to reinvigorate immunity and improve radio- and immunotherapy efficacy

    Horizon Europe · 2023–2027 · Project on CORDIS ↗

    €1.3Mtheir share
  • IgG4-TREATPartner

    Systematic study of IgG4-autoimmune diseases to develop new treatment strategies

    Horizon Europe · 2023–2027 · Project on CORDIS ↗

    €274ktheir share
  • exTraPartner

    Innovative Applications of Extracorporeal Photopheresis in Solid Organ Transplantation

    Horizon Europe · 2023–2027 · Project on CORDIS ↗

    €406ktheir share
  • INNOVATIONPartner

    Ion channels in erythrocytes: A novel understanding from regulation of erythropoiesis and physiological function to diagnostic measures and therapeutic concepts

    Horizon Europe · 2023–2027 · Project on CORDIS ↗

    €549ktheir share
  • IMMUTOLPartner

    ADVANCED ANTIGEN-SPECIFIC DENDRITIC CELL-BASED THERAPY TO RE-ESTABLISH TOLERANCE IN IMMUNE-MEDIATED DISEASES

    Horizon Europe · 2023–2027 · Project on CORDIS ↗

    €606ktheir share
  • M6ATCELLCoordinator

    Exploiting fundamental insights of m6A methylation on CD8 T cell differentiation and function to boost medicinal T cell products

    Horizon Europe · 2023–2025 · Project on CORDIS ↗

    €235ktheir share
  • RBP-ReguNetPartner

    Deconstructing and Rewiring RNA-RBP regulatory networks

    Horizon Europe · 2023–2027 · Project on CORDIS ↗

    €274ktheir share
  • REGENERATE-ITAssociated partner

    Learning from animals how to regenerate: multidisciplinary training programme in regenerative biology

    Horizon Europe · 2023–2027 · Project on CORDIS ↗

  • Maxima ButterflyAssociated partner

    From Caterpillar to BUTTERFLY: supporting transformation of DCs in a paediatric oncology network

    Horizon Europe · 2023–2027 · Project on CORDIS ↗

  • TOLERATEPartner

    An integrated approach to restore tolerance in autoimmune disease

    Horizon Europe · 2022–2026 · Project on CORDIS ↗

    €274ktheir share
  • SUPPLYPartner

    Strengthening voluntary non-remunerated plasma collection capacity in Europe

    EU4Health Programme (EU4H) · 2022–2024 · Project on the EU portal ↗

    €208ktheir share
  • SciFiMedPartner

    Screening of inFlammation to enable personalized Medicine

    Horizon 2020 · 2021–2025 · Project on CORDIS ↗

    €566ktheir share
  • COVID-REDPartner

    COVID-19 infections - Remote Early Detection

    Horizon 2020 · 2020–2022 · Project on CORDIS ↗

    €1.4Mtheir share
  • SUPPORT-EPartner

    SUPporting high quality evaluation of COVID-19 convalescent Plasma thrOughoutT Europe

    Horizon 2020 · 2020–2025 · Project on CORDIS ↗

    €437ktheir share
  • EDUC8Partner

    Early Stage Researchers EDUCational Program on Factor VIII Immunogenicity

    Horizon 2020 · 2020–2024 · Project on CORDIS ↗

    €518ktheir share
  • INsTRuCTPartner

    INnovative Training in Myeloid Regulatory Cell Therapy

    Horizon 2020 · 2020–2024 · Project on CORDIS ↗

    €266ktheir share
  • EVIDENCEPartner

    Erythrocytes properties and viability in dependence of flow and extra-cellular environment

    Horizon 2020 · 2020–2023 · Project on CORDIS ↗

    €531ktheir share
  • PRinTERsCoordinator

    Post-transcriptional regulation of effector function in T cells by RNA binding proteins

    Horizon 2020 · 2019–2024 · Project on CORDIS ↗

    €2.0Mtheir share
  • TC-EvoCoordinator

    Molecular and functional evolution of human CD8+ T cell repertoires

    Horizon 2020 · 2018–2021 · Project on CORDIS ↗

    €249ktheir share
  • RESTOREPartner

    NEURONAL SELF-RENEWAL BY ANTIGEN-SPECIFIC TOLERIZATION IN MULTIPLE SCLEROSIS REINSTALLING THE BALANCE BETWEEN INFLAMMATION AND REGENERATION

    Horizon 2020 · 2018–2023 · Project on CORDIS ↗

    €911ktheir share
  • TRANSPOSECoordinator

    TRANSfusion and transplantation: PrOtection and SElection of donors

    3rd Health Programme · 2017–2020 · Project on the EU portal ↗

    €147ktheir share
  • GlySignPartner

    Exploitation of Glycosylation Signatures for Precision Medicine

    Horizon 2020 · 2016–2020 · Project on CORDIS ↗

  • PROFILEPartner

    Innovative training network: Immunoprofile-directed stratification of patients with the autoimmune disorder thrombotic thrombocytopenic purpura

    Horizon 2020 · 2015–2019 · Project on CORDIS ↗

    €511ktheir share
  • RELEVANCEPartner

    Regulation of red cell life-span, erythropoiesis, survival, senescence and clearance

    Horizon 2020 · 2015–2019 · Project on CORDIS ↗

    €511ktheir share

Works most with

Organisations that shared the most EU projects with this one. A good starting list for consortium partners.

Fields it works in

Research fields recorded on its Horizon projects.

  • RNA
  • autoimmune diseases
  • biomolecules
  • bioreactors
  • biosensors
  • cell biology
  • cells technologies
  • chromosomes
  • coronaviruses
  • diabetes
  • diagnostic technologies
  • drug discovery
  • embryology
  • entrepreneurship

Is this your organisation?

Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.

Claim this profile →

Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships.

Europe’s tech funding.
One place.

The weekly briefing

Funding calls, VC news and key deadlines — a weekly briefing for European founders.

Free · unsubscribe anytime